Citations (526)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (56)
Benoit Follin-Arbelet, Milada Cvancarova Småstuen, Øistein Hovde, Lars-Petter Jelsness-Jørgensen & Bjørn Moum. (2023) Incidence of cancer in patients with ulcerative colitis 30 years after diagnosis (the IBSEN study). Scandinavian Journal of Gastroenterology 58:11, pages 1264-1270.
Read now
Read now
Katarzyna Gaweł, Krzysztof Dąbkowski, Iwona Zawada & Teresa Starzyńska. (2022) Progression risk factors of ulcerative proctitis. Scandinavian Journal of Gastroenterology 57:12, pages 1406-1411.
Read now
Read now
Heli Eronen, Sara Kolehmainen, Jukka Koffert, Inka Koskinen, Pia Oksanen, Airi Jussila, Heini Huhtala, Taina Sipponen & Tuire Ilus. (2022) Combining biological therapies in patients with inflammatory bowel disease: a Finnish multi-centre study. Scandinavian Journal of Gastroenterology 57:8, pages 936-941.
Read now
Read now
Axel U. Dignass, Kristine Paridaens, Sameer Al Awadhi, Jakob Begun, Jae Hee Cheon, John R. Fullarton, Edouard Louis, Fernando Magro, Juan Ricardo Marquez, Alexander R. Moschen, Neeraj Narula, Grazyna Rydzewska & Simon P. L. Travis. (2022) Multinational evaluation of clinical decision-making in the treatment and management of mild-to-moderate ulcerative colitis. Scandinavian Journal of Gastroenterology 57:4, pages 424-431.
Read now
Read now
Kristine Paridaens, John R. Fullarton & Simon P. L. Travis. (2021) Efficacy and safety of oral Pentasa (prolonged-release mesalazine) in mild-to-moderate ulcerative colitis: a systematic review and meta-analysis. Current Medical Research and Opinion 37:11, pages 1891-1900.
Read now
Read now
Federica Giachero, Andreas Jenke & Matthias Zilbauer. (2021) Improving prediction of disease outcome for inflammatory bowel disease: progress through systems medicine. Expert Review of Clinical Immunology 17:8, pages 871-881.
Read now
Read now
Vendel A. Kristensen, Randi Opheim, Gøri Perminow, Gert Huppertz-Hauss, Trond Espen Detlie, Charlotte Lund, Svend Andersen, Bjørn C. Olsen, Ingunn Johansen, Asle W. Medhus, Simen Vatn, Stephan Brackmann, Christine Olbjørn, Jon Rove, Magne Henriksen, Emma Elisabeth Løvlund, May-Bente Bengtson, Tone Bergene Aabrekk, Tor Tønnessen, Florin Berge Vikskjold, Hussain Yassin, Svein Oskar Frigstad, Audun Hasund, Ole Høie, Katharina Schmidt, Raziye Boyar Cetinkaya, Roald Torp, Erik Skogestad, Hans Kristian Holm, Tahir Riaz Ahmad, Øistein Hovde, Carl Magnus Ystrøm, Batool Aballi, Arnt Sagosen, Aina Pedersen, Stein Dahler, Jens Pallenschat, Petr Ricanek & Marte Lie Høivik. (2021) Inflammatory bowel disease in South-Eastern Norway III (IBSEN III): a new population-based inception cohort study from South-Eastern Norway. Scandinavian Journal of Gastroenterology 56:8, pages 899-905.
Read now
Read now
Anders Rönnblom & Urban Karlbom. (2021) Treatment and outcome of ulcerative colitis during the first 10 years after diagnosis in a prospectively followed population-based cohort. Scandinavian Journal of Gastroenterology 56:4, pages 403-409.
Read now
Read now
João Carlos Silva, Carlos Fernandes, Jaime Rodrigues, Sónia Fernandes, Ana Ponte, Adélia Rodrigues, Ana Paula Silva, Ana Catarina Gomes, Edgar Afecto, João Correia & João Carvalho. (2020) Endoscopic and histologic activity assessment considering disease extent and prediction of treatment failure in ulcerative colitis. Scandinavian Journal of Gastroenterology 55:10, pages 1157-1162.
Read now
Read now
Tarun Chhibba & Christopher Ma. (2020) Is there room for immunomodulators in ulcerative colitis?. Expert Opinion on Biological Therapy 20:4, pages 379-390.
Read now
Read now
Fumi Varyani, Konstantinos Argyriou, Frank Phillips, Eirini Tsakiridou & Gordon William Moran. (2019) Profile of Tofacitinib in the Treatment of Ulcerative Colitis: An Evidence-Based Review of Recent Data. Drug Design, Development and Therapy 13, pages 4091-4105.
Read now
Read now
Alok Chandra, Ravi Kanth & Sandeep Thareja. (2019) Efficacy And Safety Of Adalimumab Biosimilar (Exemptia) In Moderate-To-Severe Steroid-Refractory Ulcerative Colitis Patients: Real-Life Outcomes In Resource-Constrained Setting At 24-Weeks Follow-Up. Biologics: Targets and Therapy 13, pages 191-200.
Read now
Read now
DB Cury, R Oliveira & MS Cury. (2019) Inflammatory bowel diseases: time of diagnosis, environmental factors, clinical course, and management – a follow-up study in a private inflammatory bowel disease center (2003–2017). Journal of Inflammation Research 12, pages 127-135.
Read now
Read now
James J Ashton, Zachary Green, Vinod Kolimarala & R Mark Beattie. (2019) Inflammatory bowel disease: long-term therapeutic challenges. Expert Review of Gastroenterology & Hepatology 13:11, pages 1049-1063.
Read now
Read now
Rocío Sedano, Rodrigo Quera, Daniela Simian & Andres J. Yarur. (2019) An approach to acute severe ulcerative colitis. Expert Review of Gastroenterology & Hepatology 13:10, pages 943-955.
Read now
Read now
Karin Amcoff, Yang Cao, Yaroslava Zhulina, Maria Lampinen, Jonas Halfvarson & Marie Carlson. (2019) Prognostic significance of faecal eosinophil granule proteins in inflammatory bowel disease. Scandinavian Journal of Gastroenterology 54:10, pages 1237-1244.
Read now
Read now
Belinda Jackson & Peter De Cruz. (2018) Algorithms to facilitate shared decision-making for the management of mild-to-moderate ulcerative colitis. Expert Review of Gastroenterology & Hepatology 12:11, pages 1079-1100.
Read now
Read now
Jose María Huguet, Luis Ferrer-Barceló, Patrícia Suárez, Cecilia Albert, Lara Gonzalez, Genesis Castillo, Carlos Boix, Laura García, Juan Gallego & Javier Sempere. (2018) Endoscopic progression of ulcerative proctitis to proximal disease. Can we identify predictors of progression?. Scandinavian Journal of Gastroenterology 53:10-11, pages 1286-1290.
Read now
Read now
Alvilde Maria Ossum, Øyvind Palm, Milada Cvancarova, Inger Camilla Solberg, Morten Vatn, Bjørn Moum & Marte Lie Høivik. (2018) Peripheral arthritis in patients with long-term inflammatory bowel disease. Results from 20 years of follow-up in the IBSEN study. Scandinavian Journal of Gastroenterology 53:10-11, pages 1250-1256.
Read now
Read now
Alexandre Gherardi, Stéphane Roze, Johan Kuijvenhoven, Ola Ghatnekar & Yum Lina Yip Sonderegger. (2018) Budesonide with multi-matrix technology as second-line treatment for ulcerative colitis: evaluation of long-term cost-effectiveness in the Netherlands. Journal of Medical Economics 21:9, pages 869-877.
Read now
Read now
Sandre Svatun Lirhus, Marte Lie Høivik, Bjørn Moum & Hans Olav Melberg. (2018) Regional differences in anti-TNF-α therapy and surgery in the treatment of inflammatory bowel disease patients: a Norwegian nationwide cohort study. Scandinavian Journal of Gastroenterology 53:8, pages 952-957.
Read now
Read now
Eva Barreiro-Alonso, Cristina Saro-Gismera & Manuel Sánchez. (2018) Outcomes and prediction of corticosteroid therapy after successive courses of ulcerative colitis treatments. Expert Review of Gastroenterology & Hepatology 12:7, pages 733-741.
Read now
Read now
Cristina Bezzio, Stefano Festa, Giulia Zerboni, Claudio Papi, Gianpiero Manes & Simone Saibeni. (2018) A safety evaluation of budesonide MMX for the treatment of ulcerative colitis. Expert Opinion on Drug Safety 17:4, pages 437-444.
Read now
Read now
Robin J Dart, Mark A Samaan, Nick Powell & Peter M Irving. (2017) Vedolizumab: toward a personalized therapy paradigm for people with ulcerative colitis. Clinical and Experimental Gastroenterology 10, pages 57-66.
Read now
Read now
Tommaso Gabbani, Simona Deiana & Vito Annese. (2017) CT-P13: design, development, and place in therapy. Drug Design, Development and Therapy 11, pages 1653-1661.
Read now
Read now
Marla C. Dubinsky. (2017) Reviewing treatments and outcomes in the evolving landscape of ulcerative colitis. Postgraduate Medicine 129:5, pages 538-553.
Read now
Read now
William V. Williams. (2017) Hormonal contraception and the development of autoimmunity: A review of the literature. The Linacre Quarterly 84:3, pages 275-295.
Read now
Read now
Gert Huppertz-Hauss, Marte Lie Høivik, Lars-Petter Jelsness-Jørgensen, Randi Opheim, Magne Henriksen, Ole Høie, Øistein Hovde, Iril Kempski-Monstad, Inger Camilla Solberg, Jørgen Jahnsen, Geir Hoff, Bjørn Moum & Tomm Bernklev. (2017) Fatigue in a population-based cohort of patients with inflammatory bowel disease 20 years after diagnosis: The IBSEN study. Scandinavian Journal of Gastroenterology 52:3, pages 351-358.
Read now
Read now
Anders Rönnblom, Tommy Holmström, Hans Tanghöj, Urban Karlbom, Mari Thörn & Daniel Sjöberg. (2016) Low colectomy rate five years after diagnosis of ulcerative colitis. Results from a prospective population-based cohort in Sweden (ICURE) diagnosed during 2005–2009*. Scandinavian Journal of Gastroenterology 51:11, pages 1339-1344.
Read now
Read now
María Chaparro & Javier P. Gisbert. (2016) Maintenance therapy options for ulcerative colitis. Expert Opinion on Pharmacotherapy 17:10, pages 1339-1349.
Read now
Read now
Anne Sofie Krogh Holdam, Palle Bager & Jens Frederik Dahlerup. (2016) Biological therapy increases the health-related quality of life in patients with inflammatory bowel disease in a clinical setting. Scandinavian Journal of Gastroenterology 51:6, pages 706-711.
Read now
Read now
C. Reenaers, C. Pirard, C. Vankemseke, P. Latour, J. Belaiche & E. Louis. (2016) Long-term evolution and predictive factors of mild inflammatory bowel disease. Scandinavian Journal of Gastroenterology 51:6, pages 712-719.
Read now
Read now
Andreas Stallmach, Carsten Schmidt & Niels Teich. (2016) Vedolizumab for the treatment of ulcerative colitis. Expert Review of Gastroenterology & Hepatology 10:2, pages 165-175.
Read now
Read now
Inger Camilla Solberg, Marte Lie Høivik, Milada Cvancarova & Bjørn Moum. (2015) Risk matrix model for prediction of colectomy in a population-based study of ulcerative colitis patients (the IBSEN study). Scandinavian Journal of Gastroenterology 50:12, pages 1456-1462.
Read now
Read now
Johan Burisch & Pia Munkholm. (2015) The epidemiology of inflammatory bowel disease. Scandinavian Journal of Gastroenterology 50:8, pages 942-951.
Read now
Read now
Einar S. Björnsson & Anders Ekbom. (2015) Scandinavian epidemiological research in gastroenterology and hepatology. Scandinavian Journal of Gastroenterology 50:6, pages 636-648.
Read now
Read now
Morten H. Vatn & Arne K. Sandvik. (2015) Inflammatory bowel disease. Scandinavian Journal of Gastroenterology 50:6, pages 748-762.
Read now
Read now
Raymond K Cross. (2015) Which patients with inflammatory bowel disease should receive combination therapy?. Expert Review of Gastroenterology & Hepatology 9:6, pages 715-717.
Read now
Read now
Feng Xie. (2015) The economics of adalimumab for ulcerative colitis. Expert Review of Pharmacoeconomics & Outcomes Research 15:3, pages 373-377.
Read now
Read now
Ivana Bravatà, Gionata Fiorino, Mariangela Allocca, Alessandro Repici & Silvio Danese. (2015) New targeted therapies such as anti-adhesion molecules, anti-IL-12/23 and anti-Janus kinases are looking toward a more effective treatment of inflammatory bowel disease. Scandinavian Journal of Gastroenterology 50:1, pages 113-120.
Read now
Read now
Jon Florholmen. (2015) Mucosal healing in the era of biologic agents in treatment of inflammatory bowel disease. Scandinavian Journal of Gastroenterology 50:1, pages 43-52.
Read now
Read now
Rebecca Hein, Ingrid Köster, Elfriede Bollschweiler & Ingrid Schubert. (2014) Prevalence of inflammatory bowel disease: estimates for 2010 and trends in Germany from a large insurance-based regional cohort. Scandinavian Journal of Gastroenterology 49:11, pages 1325-1335.
Read now
Read now
Cristina Bezzio, Federica Furfaro, Roberto de Franchis, Giovanni Maconi, Anil Kumar Asthana & Sandro Ardizzone. (2014) Ulcerative colitis: current pharmacotherapy and future directions. Expert Opinion on Pharmacotherapy 15:12, pages 1659-1670.
Read now
Read now
Anthony O’Connor & Alan C Moss. (2014) Current and emerging maintenance therapies for ulcerative colitis. Expert Review of Gastroenterology & Hepatology 8:4, pages 359-368.
Read now
Read now
Klaus R Herrlinger, Eduard F Stange & Klaus Fellermann. (2014) Therapeutic peptides in inflammatory bowel disease. Expert Opinion on Biological Therapy 14:4, pages 455-466.
Read now
Read now
Bun Kim, Soo Jung Park, Sung Pil Hong, Tae Il Kim, Won Ho Kim & Jae Hee Cheon. (2014) Proximal disease extension and related predicting factors in ulcerative proctitis. Scandinavian Journal of Gastroenterology 49:2, pages 177-183.
Read now
Read now
Sudul Mananjala Senanayake, Anthony Nilesh Ranjeev Fernandopulle, Madunil Anuk Niriella, Nethini Thilanga Wijesinghe, Amanda Ranaweera, Mohammadu Nisar Mufeena, Arunasalam Pathmeswaran, Nawarathnelage Meththananda Nawarathne, Arjuna Priyadarsin de Silva & Hithanadura Janaka de Silva. (2013) The long-term outcomes of a cohort of Sri Lankan patients with ulcerative colitis: a retrospective study at two national referral centers and review of literature. Clinical and Experimental Gastroenterology 6, pages 195-200.
Read now
Read now
Alessandro Armuzzi, Daniela Pugliese, Olga Maria Nardone & Luisa Guidi. (2013) Management of difficult-to-treat patients with ulcerative colitis: focus on adalimumab. Drug Design, Development and Therapy 7, pages 289-296.
Read now
Read now
Ashwin N Ananthakrishnan. (2013) Personalizing therapy for inflammatory bowel diseases. Expert Review of Gastroenterology & Hepatology 7:6, pages 549-558.
Read now
Read now
Makoto Naganuma, Atsushi Sakuraba & Toshifumi Hibi. (2013) Ulcerative colitis: prevention of relapse. Expert Review of Gastroenterology & Hepatology 7:4, pages 341-351.
Read now
Read now
Alessandro Armuzzi & Carla Felice. (2013) Inducing remission of ulcerative colitis: are clinicians better equipped than ever?. Expert Review of Gastroenterology & Hepatology 7:2, pages 95-97.
Read now
Read now
Elana M Bern & Athos Bousvaros. (2013) Loss of response to biologics versus increased risk of lymphoma in children with inflammatory bowel disease: the clinician’s conundrum. Expert Review of Clinical Immunology 9:2, pages 117-127.
Read now
Read now
Randi Opheim, Tomm Bernklev, May Solveig Fagermoen, Milada Cvancarova & Bjorn Moum. (2012) Use of complementary and alternative medicine in patients with inflammatory bowel disease: results of a cross-sectional study in Norway. Scandinavian Journal of Gastroenterology 47:12, pages 1436-1447.
Read now
Read now
Sandro Ardizzone, Andrea Cassinotti & Roberto de Franchis. (2012) Immunosuppressive and biologic therapy for ulcerative colitis. Expert Opinion on Emerging Drugs 17:4, pages 449-467.
Read now
Read now
Glen A Doherty & Adam S Cheifetz. (2009) Management of acute severe ulcerative colitis. Expert Review of Gastroenterology & Hepatology 3:4, pages 395-405.
Read now
Read now
G. Bianchi Porro. (2009) This month in the Scandinavian Journal of Gastroenterology. Scandinavian Journal of Gastroenterology 44:4, pages 388-389.
Read now
Read now
Articles from other publishers (470)
Gabriela Świrkosz, Aleksandra Szczygieł, Katarzyna Logoń, Martyna Wrześniewska & Krzysztof Gomułka. (2023) The Role of the Microbiome in the Pathogenesis and Treatment of Ulcerative Colitis—A Literature Review. Biomedicines 11:12, pages 3144.
Crossref
Crossref
Piotr Eder, Bram Verstock, Emma Culver, Gabriele Dragoni, Lea Isabell Kredel, Joanna Wypych, Ana Garcia Garcia de Paredes, Magdalena Kaniewska, Haim Leibovitzh, Triana Lobaton, Marie Truyens, Grzegorz Oracz, Davide Giuseppe Ribaldone, Teresa Starzyńska, Abdenor Badaoui, Jean-Francois Rahier, Cristina Bezzio, Peter Bossuyt, Katherine Falloon, Daniela Pugliese, Catherine Frakes Vozzo, Tine Jess, Lone Larsen, Søren Schou Olensen, Partha Pal, María Chaparro, Dikla Dror, Pierre Ellul, Iga Gromny, Maria Janiak, Katarzyna Maciejewska, Noam Peleg, Ariella Bar-Gil Shitrit, Łukasz Szwed, Renata Talar-Wojnarowska, Yifat Snir, Roni Weisshof, Eran Zittan, Izabela Miechowicz & Idan Goren. (2023) Autoimmune Pancreatitis in Patients with Inflammatory Bowel Disease: A Real-World Multicentre Collaborative ECCO CONFER Study. Journal of Crohn's and Colitis 17:11, pages 1791-1799.
Crossref
Crossref
Manuela Distante, Silvia Rotulo, Marco Ranalli, Eugenio Pedace, Paolo Lionetti, Serena Arrigo, Patrizia Alvisi, Erasmo Miele, Massimo Martinelli, Giovanna Zuin, Matteo Bramuzzo, Mara Cananzi, Marina Aloi, M Baldi, C Banzato, G Barera, G Castellucci, M Corpino, R Cozzali, C De Giacomo, P Diaferia, D Dilillo, E Felici, M T Illiceto, D Knafelz, L Norsa, P M Pavanello, A Ravelli, V Romagnoli, C Romano & S Salvatore. (2023) Clusters of Disease Activity and Early Risk Factors of Clinical Course of Pediatric Crohn’s Disease. Inflammatory Bowel Diseases.
Crossref
Crossref
Marco Daperno. (2023) Endoscopy in IBD: When and How?. Diagnostics 13:22, pages 3423.
Crossref
Crossref
Benjamin G. Hassid, Julia Wei, Dana Sax & Fernando S. Velayos. (2023) Risk factors for recurrent emergency care utilization for flares in inflammatory bowel disease. Academic Emergency Medicine.
Crossref
Crossref
Séverine Vermeire, Jurij Hanzel, Mark Löwenberg, Marc Ferrante, Peter Bossuyt, Frank Hoentjen, Denis Franchimont, Károly Palatka, Harald Peeters, Aart Mookhoek, Gert de Hertogh, Tamás Molnár, Wouter van Moerkercke, Triana Lobatón, Esmé Clasquin, Melanie S Hulshoff, Filip Baert, Geert D’Haens, Séverine Vermeire, Mark Löwenberg, Marc Ferrante, Peter Bossuyt, Frank Hoentjen, Denis Franchimont, Károly Palatka, Harald Peeters, Tamás Molnár, Wouter van Moerkercke, Triana Lobatón, Arnaud Colard, Guy Lambrecht, Edouard Louis, Joris Dutré, Philip Caenepeel, Wout Mares, Jeroen Jansen, Janneke van der Woude, Pál Miheller, Filip Baert & Geert D’Haens. (2023) Early Versus Late Use of Vedolizumab in Ulcerative Colitis: Clinical, Endoscopic, and Histological Outcomes. Journal of Crohn's and Colitis.
Crossref
Crossref
Arash Assadsangabi, Caroline A Evans, Bernard M Corfe & Alan J Lobo. (2023) Exploring Predictive Biomarkers of Relapse in Ulcerative Colitis: A Proteomics Approach. Inflammatory Bowel Diseases.
Crossref
Crossref
Soo-Young Na. (2023) Advancements in the Management of Moderate-to-Severe Ulcerative Colitis: A Revised 2023 Korean Treatment Guidelines. The Korean Journal of Medicine 98:5, pages 223-230.
Crossref
Crossref
Claudia Herrera-deGuise, Encarna Varela, Guillaume Sarrabayrouse, Marta Pozuelo del Río, Virginia Robles Alonso, Natalia Borruel Sainz, Francesc Casellas, Luis Fernando Mayorga, Chaysavanh Manichanh, Fernando Azpiroz Vidaur & Francisco Guarner. (2023) Gut Microbiota Composition in Long-Remission Ulcerative Colitis is Close to a Healthy Gut Microbiota. Inflammatory Bowel Diseases 29:9, pages 1362-1369.
Crossref
Crossref
Wei Guan & Wang Qi. (2023) Ginsenoside Rh2: A shining and potential natural product in the treatment of human nonmalignant and malignant diseases in the near future. Phytomedicine 118, pages 154938.
Crossref
Crossref
Elizabeth A. Spencer. (2023) Choosing the Right Therapy at the Right Time for Pediatric Inflammatory Bowel Disease. Gastroenterology Clinics of North America 52:3, pages 517-534.
Crossref
Crossref
Wenyu Jiang, Meijiao LuLi Zhang, Chenjing Xu, Ruohan Wang, Ying Xu, Wen TangHongjie Zhang. (2023) Optimizing individualized management of patients with ulcerative colitis: Identification of risk factors predicting ulcerative colitis-associated neoplasia. Medicine 102:32, pages e34729.
Crossref
Crossref
Paula Sousa, Lorenzo Bertani & Cláudio Rodrigues. (2023) Management of inflammatory bowel disease in the elderly: A review. Digestive and Liver Disease 55:8, pages 1001-1009.
Crossref
Crossref
James Varani, Shannon D. McClintock, Daniyal M. Nadeem, Isabelle Harber, Dania Zeidan & Muhammad N. Aslam. (2023) A multi-mineral intervention to counter pro-inflammatory activity and to improve the barrier in human colon organoids. Frontiers in Cell and Developmental Biology 11.
Crossref
Crossref
Noa Tal, Christos Tzivinikos, Marco Gasparetto, Daniela E Serban, Eyal Zifman, Iva Hojsak, Oren Ledder, Anat Yerushalmy Feler, Helena Rolandsdotter, Marina Aloi, Matteo Bramuzzo, Stephan Buderus, Paolo Lionetti, Lorenzo Norsa, Christoph Norden, Darja Urlep, Claudio Romano, Ron Shaoul, Christine Martinez-Vinson, Anna Karoliny, Elisabeth De Greef, Ben Kang, Eva VIčková, Patrizia Alvisi, Michal Kori, Marta Tavares, Batia Weiss, Seamus Hussey, Maria E Qamhawi, Laura M Palomino Pérez, Paul Henderson, Raj Parmar, Erasmo Miele, Firas Rinawi, Ana Lozano-Ruf, Veena Zamvar, Kaija-Leena Kolho & Dror S Shouval. (2023) Clinical Features and Natural History of Paediatric Patients with Ulcerative Proctitis: A Multicentre Study from the Paediatric IBD Porto Group of ESPGHAN. Journal of Crohn's and Colitis.
Crossref
Crossref
Massimo Martinelli, Flora Fedele, Claudio Romano, Marina Aloi, Paolo Lionetti, Patrizia Alvisi, Serena Arrigo, Luca Bosa, Matteo Bramuzzo, Giulia D'Arcangelo, Valeria Dipasquale, Enrico Felici, Maurizio Fuoti, Simona Gatti, Francesco Graziano, Maria Teresa Illiceto, Flavio Labriola, Lorenzo Norsa, Maria Pastore, Luca Scarallo, Caterina Strisciuglio, Giovanna Zuin, Erasmo Miele & Annamaria Staiano. (2023) Disease course of ulcerative proctitis in children: A population-based study on behalf of the SIGENP IBD Group. Digestive and Liver Disease.
Crossref
Crossref
Yunfei Pu, Xianzhi Meng & Zhichen Zou. (2023) Identification and immunological characterization of cuproptosis-related molecular clusters in ulcerative colitis. BMC Gastroenterology 23:1.
Crossref
Crossref
Johan Burisch. (2023) Long‐term disease course, cost and prognosis of inflammatory bowel disease: epidemiological studies of a European and a Danish inception cohort. APMIS 131:S147, pages 1-46.
Crossref
Crossref
Panu Wetwittayakhlang, Lorant Gonczi, Laszlo Lakatos, Zsuzsanna Kurti, Petra Golovics, Tunde Pandur, Gyula David, Zsuzsanna Erdelyi, Istvan Szita & Peter L Lakatos. (2023) Long-term Colectomy Rates of Ulcerative Colitis over 40 Years of Different Therapeutic Eras–Results from a Western Hungarian Population-based Inception Cohort Between 1977 and 2020. Journal of Crohn's and Colitis 17:5, pages 712-721.
Crossref
Crossref
Maro Kyriacou, Shellie Radford & Gordon W Moran. (2023) Delphi consensus survey: the opinions of patients living with refractory ulcerative proctitis and the health care professionals who care for them. BMJ Open Gastroenterology 10:1, pages e001139.
Crossref
Crossref
Bailu Geng, Xueli Ding, Xiaoyu Li, Hua Liu, Wenjun Zhao, Haihong Gong, Zibin Tian & Jing Guo. (2023) Peripheral blood T-lymphocyte subsets are potential biomarkers of disease severity and clinical outcomes in patients with ulcerative colitis: a retrospective study. BMC Gastroenterology 23:1.
Crossref
Crossref
Anton Risto, Caroline Nordenvall, Mohammed Deputy, Maria Hermanson, Ulrik Lindforss, Mattias Block, Omar Faiz & Pär Myrelid. (2023) Colectomy reconstruction for ulcerative colitis in Sweden and England: a multicenter prospective comparison between ileorectal anastomosis and ileal pouch-anal anastomosis after colectomy in patients with ulcerative colitis. (CRUISE-study). BMC Surgery 23:1.
Crossref
Crossref
Benoit Follin-Arbelet, Milada Cvancarova Småstuen, Øistein Hovde, Lars-Petter Jelsness-Jørgensen & Bjørn Moum. (2023) Mortality in Patients with Inflammatory Bowel Disease: Results from 30 Years of Follow-up in a Norwegian Inception Cohort (the IBSEN study). Journal of Crohn's and Colitis 17:4, pages 497-503.
Crossref
Crossref
Cordelia Schuler, Federica Foti, Leonie Perren, Céline Mamie, Bruce Weder, Michelle Stokmaier, Cheryl de Vallière, Rainer Heuchel, Pedro A Ruiz, Gerhard Rogler & Martin Hausmann. (2023)
Deletion of
Smad7
Ameliorates Intestinal Inflammation and Contributes to Fibrosis
. Inflammatory Bowel Diseases 29:4, pages 647-660.
Crossref
Crossref
Silje Welsh, Zihao Sam, John Paul Seenan & Gary A Nicholson. (2023) The Role of Appendicectomy in Ulcerative Colitis: Systematic Review and Meta-Analysis. Inflammatory Bowel Diseases 29:4, pages 633-646.
Crossref
Crossref
Mads Damsgaard Wewer, Ebbe Langholz, Pia Munkholm, Flemming Bendtsen, Jakob Benedict Seidelin & Johan Burisch. (2023) Disease Activity Patterns of Inflammatory Bowel Disease—A Danish Nationwide Cohort Study 1995–2018. Journal of Crohn's and Colitis 17:3, pages 329-337.
Crossref
Crossref
Pauline Wils & Laurent Peyrin-Biroulet. (2023) Etrasimod for the treatment of ulcerative colitis. Immunotherapy 15:5, pages 311-321.
Crossref
Crossref
Mohineesh Kumar, Rachel N. Harvey, Samuel K. Osei, Ayesha Fatima, Alexander Z. Menning, Begum Akay, Pavan Brahmamdam, Anthony Stallion & Nathan M. Novotny. (2023) The Evolving Effectiveness of Biologics in Avoiding Surgery in Children With Ulcerative Colitis: At what Nutritional Cost?. The American Surgeon, pages 000313482311617.
Crossref
Crossref
Guozhen Wang, Yongshuai Qi, Jia Xu, Yun Huang, Feng Xiong, Weichang Huang, Xiaoxin Ma, Shuanghu Wang, Changxiong Wang, Yunfang Zhou & Lisheng Wang. (2023) Neutrophil Membrane-Coated Mesoporous Silica Nanoparticles Loaded with Hydrocortisone Alleviate DSS-Induced Colitis in Mice. ACS Applied Nano Materials 6:4, pages 2403-2412.
Crossref
Crossref
Soo-Young Na, Chang Hwan Choi, Eun Mi Song, Ki Bae Bang, Sang Hyoung Park, Eun Soo Kim, Jae Jun Park, Bora Keum, Chang Kyun Lee, Bo-In Lee, Seung-Bum Ryoo, Seong-Joon Koh, Miyoung Choi & Joo Sung Kim. (2023) Korean clinical practice guidelines on biologics and small molecules for moderate-to-severe ulcerative colitis. Intestinal Research 21:1, pages 61-87.
Crossref
Crossref
Kwangwoo Nam, Jae Yong Lee, Yousun Ko, Kyung Won Kim, Ho-Su Lee, Seung Wook Hong, Jin Hwa Park, Sung Wook Hwang, Dong-Hoon Yang, Byong Duk Ye, Jeong-Sik Byoun, Seung-Jae Myung, Suk-Kyun Yang & Sang Hyoung Park. (2023) Impact of Sarcopenia on Clinical Course of Inflammatory Bowel Disease in Korea. Digestive Diseases and Sciences.
Crossref
Crossref
Shengduo He, Hong Jiang, Yu Tian, Wei Zhang, Guigen Teng & Huahong Wang. (2023) Ulcerative Colitis Overall Disease Severity Index Predicts Colectomy: A Prospective Cohort Study. Revista Española de Enfermedades Digestivas 115.
Crossref
Crossref
Nick Dai, Omar Haidar, Alan Askari & Jonathan P Segal. (2023) Colectomy rates in ulcerative colitis: A systematic review and meta-analysis. Digestive and Liver Disease 55:1, pages 13-20.
Crossref
Crossref
Stephan Brand. 2023. Pflege bei chronisch-entzündlichen Darmerkrankungen. Pflege bei chronisch-entzündlichen Darmerkrankungen
43
69
.
Noa Krugliak Cleveland, Brian Bressler, Corey A. Siegel, Leonard Baidoo, Brian Bressler, Adam S. Cheifetz, Jean-Frederic Colombel, Parakkal Deepak, Shane Devlin, Peter M. Irving, Noa Krugliak Cleveland, Gil Y. Melmed, Laura E. Raffals, Florian Rieder, David T. Rubin, Corey A. Siegel, Miles P. Sparrow, Joana Torres, Thomas Ullman & Fernando Velayos. (2022) A Summary of the BRIDGe Summit on Damage-Related Progression of Ulcerative Colitis: Establishing Research Priorities. Gastroenterology 163:6, pages 1505-1509.
Crossref
Crossref
Kay-Martin Johnsen, Jon Florholmen, Øystein K. Moe, Mona Gundersen, Julia Beilfuss, Hege Kileng, Sveinung W. Sørbye & Rasmus Goll. (2022) Prediction of long-term remission in patients following discontinuation of anti-TNF therapy in ulcerative colitis: a 10 year follow up study. BMC Gastroenterology 22:1.
Crossref
Crossref
Sabrina Schnur, Vanessa Wahl, Julia K. Metz, Jessica Gillmann, Fabian Hans, Katharina Rotermund, Ralf-Kilian Zäh, Dietmar A. Brück, Marc Schneider & Marius Hittinger. (2022) Inflammatory bowel disease addressed by Caco-2 and monocyte-derived macrophages: an opportunity for an in vitro drug screening assay. In vitro models 1:4-5, pages 365-383.
Crossref
Crossref
Megan E. Murphy, Sumona Bhattacharya & Jordan E. Axelrad. (2022) Diagnosis and Monitoring of Ulcerative Colitis. Clinics in Colon and Rectal Surgery 35:06, pages 421-427.
Crossref
Crossref
Bénédicte Caron, Maria T. Abreu, Corey A. Siegel, Remo Panaccione, Bruce E. Sands, Axel Dignass, Dan Turner, Iris Dotan, Ailsa L. Hart, Vineet Ahuja, Matthieu Allez, Ashwin N. Ananthakrishnan, Subrata Ghosh, Anne M. Griffiths, Jonas Halfvarson, Arthur Kaser, Paulo G. Kotze, Ioannis E. Koutroubakis, Peter L. Lakatos, Arie Levine, James D. Lewis, Fernando Magro, Gerassimos J. Mantzaris, Colm O’Morain, Zhihua Ran, Walter Reinisch, Gerhard Rogler, David B. Sachar, Britta Siegmund, Mark S. Silverberg, Ajit Sood, Antonino Spinelli, Flavio Steinwurz, Curt Tysk, Jesus K. Yamamoto-Furusho, Stefan Schreiber, David T. Rubin, William J. Sandborn, Silvio Danese & Laurent Peyrin-Biroulet. (2022) IOIBD Recommendations for Clinical Trials in Ulcerative Proctitis: The PROCTRIAL Consensus. Clinical Gastroenterology and Hepatology 20:11, pages 2619-2627.e1.
Crossref
Crossref
Eun Mi Song & Suk-Kyun Yang. (2022) Natural history of inflammatory bowel disease: a comparison between the East and the West. Intestinal Research 20:4, pages 418-430.
Crossref
Crossref
Salvatore Magrì, Mauro Demurtas, Maria Francesca Onidi, Marcello Picchio, Walter Elisei, Manuela Marzo, Federica Miculan, Roberto Manca, Maria Pina Dore, Bianca Maria Quarta Colosso, Antonio Cicu, Luigi Cugia, Monica Carta, Laura Binaghi, Paolo Usai, Mariantonia Lai, Fabio Chicco, Massimo Claudio Fantini, Alessandro Armuzzi & Giammarco Mocci. (2022) Clinical and epidemiological features of ulcerative colitis patients in Sardinia, Italy: Results from a multicenter study. World Journal of Clinical Cases 10:30, pages 10921-10930.
Crossref
Crossref
Elizabeth A. Spencer, Manasi Agrawal & Tine Jess. (2022) Prognostication in inflammatory bowel disease. Frontiers in Medicine 9.
Crossref
Crossref
Jae Song Kim, Min Jung Geum, Eun Sun Son, Yun Mi Yu, Jae Hee Cheon & Kyeng Hee Kwon. (2022) Improvement in Medication Adherence after Pharmacist Intervention Is Associated with Favorable Clinical Outcomes in Patients with Ulcerative Colitis. Gut and Liver 16:5, pages 736-745.
Crossref
Crossref
Karin Westberg, Ola Olén, Jonas Söderling, Jonas Bengtsson, Jonas F Ludvigsson, Åsa H Everhov, Pär Myrelid & Caroline Nordenvall. (2022) Primary Versus Staged Reconstruction and Risk of Surgical Failure in Patients With Ulcerative Colitis: a Nation-wide Cohort Study. Inflammatory Bowel Diseases 28:9, pages 1301-1308.
Crossref
Crossref
Su Hyun Park & Sang Hyoung Park. (2022) Personalized medicine in inflammatory bowel disease: Perspectives on Asia. Journal of Gastroenterology and Hepatology 37:8, pages 1434-1445.
Crossref
Crossref
Mohamed A. Abd El Aziz, David W. Larson, Fabian Grass, Anne-Lise D. D’Angelo, Scott R. Kelley, Laura E. Raffals, Kellie L. Mathis & Sherief Shawki. (2022) Emergent and Urgent Surgery for Ulcerative Colitis in the United States in the Minimally Invasive and Biologic Era. Diseases of the Colon & Rectum 65:8, pages 1025-1033.
Crossref
Crossref
Eduardo J. Villablanca, Katja Selin & Charlotte R. H. Hedin. (2022) Mechanisms of mucosal healing: treating inflammatory bowel disease without immunosuppression?. Nature Reviews Gastroenterology & Hepatology 19:8, pages 493-507.
Crossref
Crossref
Kyeong Ok Kim. (2022) Endoscopic activity in inflammatory bowel disease: clinical significance and application in practice. Clinical Endoscopy 55:4, pages 480-488.
Crossref
Crossref
Yiyoung Kwon, Eun Sil Kim, Yon Ho Choe & Mi Jin Kim. (2022) How has the disease course of pediatric ulcerative colitis changed throughout the biologics era? A comparison with the IBSEN study. World Journal of Gastroenterology 28:28, pages 3666-3681.
Crossref
Crossref
Bénédicte Caron, William J Sandborn, Remo Panaccione, Stefan Schreiber, Ailsa Hart, Virginia Solitano, Silvio Danese & Laurent Peyrin-Biroulet. (2022) Efficacy of Pharmacological Agents for Ulcerative Proctitis: A Systematic Literature Review. Journal of Crohn's and Colitis 16:6, pages 922-930.
Crossref
Crossref
Francesca Ferretti, Rosanna Cannatelli, Maria Camilla Monico, Giovanni Maconi & Sandro Ardizzone. (2022) An Update on Current Pharmacotherapeutic Options for the Treatment of Ulcerative Colitis. Journal of Clinical Medicine 11:9, pages 2302.
Crossref
Crossref
Noa Krugliak Cleveland, Joana Torres & David T. Rubin. (2022) What Does Disease Progression Look Like in Ulcerative Colitis, and How Might It Be Prevented?. Gastroenterology 162:5, pages 1396-1408.
Crossref
Crossref
Christopher A. Lamb, Aamir Saifuddin, Nick Powell & Florian Rieder. (2022) The Future of Precision Medicine to Predict Outcomes and Control Tissue Remodeling in Inflammatory Bowel Disease. Gastroenterology 162:5, pages 1525-1542.
Crossref
Crossref
Yansheng Hao, Clara Yzet, Russell B. McBride, Aryeh Stock, Elisa Tiratterra, Antonietta D’Errico, Andrea Belluzzi, Eleonora Scaioli, Paolo Gionchetti, Giulia Roda, Ryan Ungaro, Jean-Frederic Colombel, Noam Harpaz & Huaibin Mabel Ko. (2021) Baseline Histological Findings Do Not Predict the Risk of Subsequent Extension in Patients with Limited Ulcerative Colitis. Digestive Diseases and Sciences 67:4, pages 1311-1319.
Crossref
Crossref
Paulina Ballesta, Sunny Ahmar, Gustavo A. Lobos, Daniel Mieres-Castro, Felipe Jiménez-Aspee & Freddy Mora-Poblete. (2022) Heritable Variation of Foliar Spectral Reflectance Enhances Genomic Prediction of Hydrogen Cyanide in a Genetically Structured Population of Eucalyptus. Frontiers in Plant Science 13.
Crossref
Crossref
Rocio Sedano, Tran M Nguyen, Ahmed Almradi, Florian Rieder, Claire E Parker, Lisa M Shackelton, Geert D’Haens, William J Sandborn, Brian G Feagan, Christopher Ma & Vipul Jairath. (2022) Disease Activity Indices for Pouchitis: A Systematic Review. Inflammatory Bowel Diseases 28:4, pages 622-638.
Crossref
Crossref
Niels Vande Casteele, Jonathan A Leighton, Shabana F Pasha, Frank Cusimano, Aart Mookhoek, Catherine E Hagen, Christophe Rosty, Reetesh K Pai & Rish K Pai. (2022) Utilizing Deep Learning to Analyze Whole Slide Images of Colonic Biopsies for Associations Between Eosinophil Density and Clinicopathologic Features in Active Ulcerative Colitis. Inflammatory Bowel Diseases 28:4, pages 539-546.
Crossref
Crossref
Shengbao Wang, Lingling Zhen, Xiaoli Li, Xu Fu, Peiwu Li & Dekui Zhang. (2022) Search for Key Genes and Functional Pathways of Ulcerative Colitis to Colon Cancer Based on Bioinformatics. Frontiers in Oncology 12.
Crossref
Crossref
Carsten Schmidt, Bernd Bokemeyer, Andreas Lügering, Dominik Bettenworth, Niels Teich, Imma Fischer, Leonie Hammer, Stefanie Kolterer, Stefan Rath & Andreas Stallmach. (2022) Clinical predictors for a complicated course of disease in an inception cohort of patients with ulcerative colitis: results from the prospective, observational EPICOL study. International Journal of Colorectal Disease 37:2, pages 485-493.
Crossref
Crossref
Danny Con, Bridgette Andrew, Steven Nicolaides, Daniel R van Langenberg & Abhinav Vasudevan. (2022) Biomarker dynamics during infliximab salvage for acute severe ulcerative colitis: C-reactive protein (CRP)-lymphocyte ratio and CRP-albumin ratio are useful in predicting colectomy. Intestinal Research 20:1, pages 101-113.
Crossref
Crossref
Jian Wan, Xuan Wang, Yujie Zhang, Xianmin Xue, Hui Jia, Min Wang, Jie Liang & Kaichun Wu. (2022) Time-adjusted average Mayo endoscopic score predicts the risk of disease extent progression in distal ulcerative colitis patients. Gastroenterology Report 10.
Crossref
Crossref
Rahul Jain, Vani Singh, AK Naik, SantoshKumar Singh, BarunKumar Chakrabarty, Priya Ranjan & Premshankar Kumar. (2022) Causes, frequencies, and predictors of relapse in patients with ulcerative colitis on long-term follow-up in a tertiary care hospital of Northern India. Journal of Marine Medical Society 24:1, pages 94.
Crossref
Crossref
Ryuichi Kuwahara, Hiroki Ikeuchi, Kurando Kusunoki, Tomohiro Minagawa, Yuki Horio, Kei Kimura, Naohito Beppu, Masataka Ikeda & Motoi Uchino. (2022) Clinical Results Following Emergency Surgery in 391 Patients with Ulcerative Colitis潰瘍性大腸炎に対する緊急手術391例の検討. Nippon Daicho Komonbyo Gakkai Zasshi 75:7, pages 333-338.
Crossref
Crossref
Georgios Mavroudis, Magnus Simrén, Lena Öhman & Hans Strid. (2022) Health-related quality of life in patients with long-standing ulcerative colitis in remission. Therapeutic Advances in Gastroenterology 15, pages 175628482110624.
Crossref
Crossref
Anton Risto, Maie Abdalla & Pär Myrelid. (2022) Staging Pouch Surgery in Ulcerative Colitis in the Biological Era. Clinics in Colon and Rectal Surgery 35:01, pages 058-065.
Crossref
Crossref
Cristina Rodríguez, Alfonso Elosua, Carlos Prieto, Ernesto Pérez, Rebeca Irisarri, Ana Campillo, Saioa Rubio, Óscar Nantes, Ramón Angós & José Manuel Zozaya. (2022) Tasas de colectomía en colitis ulcerosa 15 años después del diagnóstico. Datos de la cohorte Navarra 2001-2003. Gastroenterología y Hepatología 45:1, pages 1-8.
Crossref
Crossref
Cristina Rodríguez, Alfonso Elosua, Carlos Prieto, Ernesto Pérez, Rebeca Irisarri, Ana Campillo, Saioa Rubio, Óscar Nantes, Ramón Angós & José Manuel Zozaya. (2022) Colectomy rate in ulcerative colitis 15 years after diagnosis: Results from the 2001-2003 Navarra cohort. Gastroenterología y Hepatología (English Edition) 45:1, pages 1-8.
Crossref
Crossref
Georgios Michalopoulos & Konstantinos Karmiris. (2022) When disease extent is not always a key parameter: Management of refractory ulcerative proctitis. Current Research in Pharmacology and Drug Discovery 3, pages 100071.
Crossref
Crossref
Lesley A. Graff & Jeffrey M. Lackner. 2022. Comprehensive Clinical Psychology. Comprehensive Clinical Psychology
268
288
.
Kristin Kassel & Mario A. Pfannstiel. 2022. Künstliche Intelligenz im Gesundheitswesen. Künstliche Intelligenz im Gesundheitswesen
431
450
.
Loren Galler Rabinowitz, Stephanie Lauren Gold & Elana A. Maser. 2022. Management of Inpatient Inflammatory Bowel Disease. Management of Inpatient Inflammatory Bowel Disease
31
67
.
Mahvash Alizade Naini, Asal Zargari-Samadnejad, Shayan Mehrvarz, Romina Tanideh, Mohammad Ghorbani, Amirreza Dehghanian, Maryam Hasanzarrini, Farnaz Banaee, Omid Koohi-Hosseinabadi, Nader Tanideh & Aida Iraji. (2021) Anti-Inflammatory, Antioxidant, and Healing-Promoting Effects of Aloe vera Extract in the Experimental Colitis in Rats. Evidence-Based Complementary and Alternative Medicine 2021, pages 1-12.
Crossref
Crossref
Kwangwoo Nam, Sang Hyoung Park, Jun Ho Oh, Ho-Su Lee, Soomin Noh, Jae Cheol Park, Jin Yong Kim, Eun Hye Oh, Jeongseok Kim, Nam Seok Ham, Sung Wook Hwang, Dong-Hoon Yang, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung & Suk-Kyun Yang. (2021) Prevalence and risk factors of bowel symptoms in Korean patients with ulcerative colitis in endoscopic remission: a retrospective study. BMC Gastroenterology 21:1.
Crossref
Crossref
Viraj C. Kariyawasam, Fadi H. Mourad, Nikola Mitrev, Sudarshan Paramsothy, Christian P. Selinger, Peter H. Katelaris, Brian Jones, Charles McDonald, Gavin Barr, Grace Chapman, James Cowlishaw, Jane Andrews & Rupert W. Leong. (2021) Early thiopurine maintenance is associated with reduced proximal disease progression and colectomy rate in ulcerative colitis. European Journal of Gastroenterology & Hepatology 33:12, pages 1524-1532.
Crossref
Crossref
Panu Wetwittayakhlang, Livia Lontai, Lorant Gonczi, Petra A. Golovics, Gustavo Drügg Hahn, Talat Bessissow & Peter L. Lakatos. (2021) Treatment Targets in Ulcerative Colitis: Is It Time for All In, including Histology?. Journal of Clinical Medicine 10:23, pages 5551.
Crossref
Crossref
Yunki Y Yau, Valerie C Wasinger, Robert P Hirten, Emil Chuang, Merodean Huntsman, Jack Stylli, Jeff Shimizu, Vijay Yajnik, Jeffrey Smith, Shaoying N Lee, Sharat Singh, Christopher Wahl, Rupert W Leong & Bruce E Sands. (2021) Current Trends in IBD—Development of Mucosal-Based Biomarkers and a Novel Minimally Invasive Recoverable Sampling System. Inflammatory Bowel Diseases 27:Supplement_2, pages S17-S24.
Crossref
Crossref
U. Helwig. (2021) 22/w mit Unterbauchschmerzen und Blut im Stuhl22 years old woman presenting with lower abdominal pain and fecal blood. Der Internist 62:S5, pages 561-564.
Crossref
Crossref
Tim Raine, Bram Verstockt, Uri Kopylov, Konstantinos Karmiris, Rimma Goldberg, Raja Atreya, Johan Burisch, John Burke, Pierre Ellul, Charlotte Hedin, Stefan D Holubar, Konstantinos Katsanos, Triana Lobaton, Carsten Schmidt & Garret Cullen. (2021) ECCO Topical Review: Refractory Inflammatory Bowel Disease. Journal of Crohn's and Colitis 15:10, pages 1605-1620.
Crossref
Crossref
Mary E Sherlock, Mary Zachos, Robert M Issenman & Daniel J Mulder. (2021) Clinical and Laboratory Characteristics Are Associated With Biologic Therapy Use in Pediatric Inflammatory Bowel Disease: A Retrospective Cohort Study. Journal of the Canadian Association of Gastroenterology 4:5, pages e92-e100.
Crossref
Crossref
Klaus R. Herrlinger & Eduard F. Stange. (2021) Twenty‐five years of biologicals in IBD: What´s all the hype about?. Journal of Internal Medicine 290:4, pages 806-825.
Crossref
Crossref
Carsten SchmidtOliver Bachmann, Daniel C. Baumgart, Martin Goetz, Oliver Drvarov, Torsten F. Kucharzik, Tanja Kühbacher, Jost Langhorst, Jochen Maul, Wolfgang Mohl, Jonas Mudter, Michael Repp, Andreas Sturm, Dieter Witzemann & Raja Atreya. (2021) Positionspapier zur Befunderstellung endoskopischer Untersuchungen bei Patienten mit chronisch-entzündlichen Darmerkrankungen. Zeitschrift für Gastroenterologie 59:10, pages 1091-1109.
Crossref
Crossref
Lester Tsai, Christopher Ma, Parambir S. Dulai, Larry J. Prokop, Samuel Eisenstein, Sonia L. Ramamoorthy, Brian G. Feagan, Vipul Jairath, William J. Sandborn & Siddharth Singh. (2021) Contemporary Risk of Surgery in Patients With Ulcerative Colitis and Crohn’s Disease: A Meta-Analysis of Population-Based Cohorts. Clinical Gastroenterology and Hepatology 19:10, pages 2031-2045.e11.
Crossref
Crossref
Mirabella Zhao, Lóránt Gönczi, Peter L Lakatos & Johan Burisch. (2021) The Burden of Inflammatory Bowel Disease in Europe in 2020. Journal of Crohn's and Colitis 15:9, pages 1573-1587.
Crossref
Crossref
Clément Bresteau, Aurélien Amiot, Julien Kirchgesner, Nicola de'Angelis, Jérémie H. Lefevre, Yoram Bouhnik, Yves Panis, Laurent Beaugerie, Matthieu Allez, Antoine Brouquet, Franck Carbonnel & Antoine Meyer. (2021) Chronic pouchitis and Crohn's disease of the pouch after ileal pouch-anal anastomosis: Incidence and risk factors. Digestive and Liver Disease 53:9, pages 1128-1135.
Crossref
Crossref
René Roth, Stephan Vavricka, Michael Scharl, Philipp Schreiner, Ekaterina Safroneeva, Thomas Greuter, Jonas Zeitz, Benjamin Misselwitz, Alain Schoepfer, Mamadou Pathé Barry, Gerhard Rogler & Luc Biedermann. (2021) The impact of colectomy on the course of extraintestinal manifestations in Swiss inflammatory bowel disease cohort study patients. United European Gastroenterology Journal 9:7, pages 773-780.
Crossref
Crossref
Jin Young Yoon, Jae Myung Cha, Chang Kyun Lee, Young Sook Park, Kyu Chan Huh, Jeong Eun Shin, You Sun Kim, Chang Soo Eun, Soon Man Yoon, Jae Hee Cheon, Young Soo Park, Byong Duk Ye, YoungJa Lee, Youngdoe Kim & Hyo Jong Kim. (2021) Early course of newly diagnosed moderate‐to‐severe ulcerative colitis in Korea: Results from a hospital‐based inception cohort study (MOSAIK). Journal of Gastroenterology and Hepatology 36:8, pages 2149-2156.
Crossref
Crossref
Bénédicte Caron, William J Sandborn, Stefan Schreiber, Remo Panaccione, Silvio Danese & Laurent Peyrin-Biroulet. (2021) Drug development for ulcerative proctitis: current concepts. Gut 70:7, pages 1203-1209.
Crossref
Crossref
Stefan D. Holubar, Amy L. Lightner, Vitaliy Poylin, Jon D. Vogel, Wolfgang Gaertner, Bradley Davis, Kurt G. Davis, Uma Mahadevan, Samir A. Shah, Sunanda V. Kane, Scott R. Steele, Ian M. Paquette & Daniel L. Feingold. (2021) The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Surgical Management of Ulcerative Colitis. Diseases of the Colon & Rectum 64:7, pages 783-804.
Crossref
Crossref
Manasi Agrawal, Elizabeth A. Spencer, Jean-Frederic Colombel & Ryan C. Ungaro. (2021) Approach to the Management of Recently Diagnosed Inflammatory Bowel Disease Patients: A User’s Guide for Adult and Pediatric Gastroenterologists. Gastroenterology 161:1, pages 47-65.
Crossref
Crossref
Séverine Vermeire, Michael Chiorean, Julián Panés, Laurent Peyrin-Biroulet, Jinkun Zhang, Bruce E Sands, Krisztina Lazin, Preston Klassen, Snehal U Naik, Christopher H Cabell & William J Sandborn. (2021) Long-term Safety and Efficacy of Etrasimod for Ulcerative Colitis: Results from the Open-label Extension of the OASIS Study. Journal of Crohn's and Colitis 15:6, pages 950-959.
Crossref
Crossref
Iril Lovise Monstad, Inger Camilla Solberg, Milada Cvancarova, Oistein Hovde, Magne Henriksen, Gert Huppertz-Hauss, Eva Gunther, Bjørn Allan Moum, Njaal Stray, Morten Vatn, Ole Hoie & Jørgen Jahnsen. (2021) Outcome of Ulcerative Colitis 20 Years after Diagnosis in a Prospective Population-based Inception Cohort from South-Eastern Norway, the IBSEN Study. Journal of Crohn's and Colitis 15:6, pages 969-979.
Crossref
Crossref
David T Rubin, Ailsa Hart, Remo Panaccione, Alessandro Armuzzi, Ulla Suvanto, J Jasper Deuring, John Woolcott, Joseph C Cappelleri, Kathy Steinberg, Laura Wingate & Stefan Schreiber. (2021) Ulcerative Colitis Narrative Global Survey Findings: Communication Gaps and Agreements Between Patients and Physicians. Inflammatory Bowel Diseases 27:7, pages 1096-1106.
Crossref
Crossref
Iman Shifa, Glen S. Hazlewood, Caylib Durand, Susan G. Barr, P. Régine Mydlarski, Paul L. Beck, Jodie M. Burton, Faisal M. Khan, Kareem Jamani, Mohamed Osman & Jan Storek. (2021) Efficacy of Allogeneic Hematopoietic Cell Transplantation for Autoimmune Diseases. Transplantation and Cellular Therapy 27:6, pages 489.e1-489.e9.
Crossref
Crossref
Rocio Sedano, Christopher Ma, Rish K. Pai, Geert D' Haens, Leonardo Guizzetti, Lisa M. Shackelton, Julie Remillard, Paolo Gionchetti, Ilyssa O. Gordon, Stefan Holubar, Maia Kayal, Gregory Y. Lauwers, Reetesh K. Pai, Darrell S. Pardi, Mark A. Samaan, David F. Schaeffer, Bo Shen, Mark S. Silverberg, Brian G. Feagan, William J. Sandborn & Vipul Jairath. (2021) An expert consensus to standardise clinical, endoscopic and histologic items and inclusion and outcome criteria for evaluation of pouchitis disease activity in clinical trials. Alimentary Pharmacology & Therapeutics 53:10, pages 1108-1117.
Crossref
Crossref
Catherine Le Berre, Laurent Peyrin-Biroulet, William J. Sandborn, Jean-Frédéric Colombel, David Rubin, Yehuda Chowers, Walter Reinisch, Stefan Schreiber, Matthieu Allez, Geert D’Haens, Subrata Ghosh, Ioannis E. Koutroubakis, Peter Gibson, Jonas Halfvarson, Ailsa Hart, Arthur Kaser, Pia Munkholm, Wolfgang Kruis, Severine Vermeire, Edward V. LoftusJr.Jr., Milan Lukas, Gerassimos J. Mantzaris, Colm O’Morain, Julian Panes, Gerhard Rogler, Antonino Spinelli, Bruce E. Sands, Aswhin N. Ananthakrishnan, Siew C. Ng, David Sachar, Simon Travis, Flavio Steinwurz, Dan Turner, Parambir S. Dulai, Vipul Jairath, Iris Dotan, Maria Abreu, Remo Panaccione & Silvio Danese. (2021) Selecting End Points for Disease-Modification Trials in Inflammatory Bowel Disease: the SPIRIT Consensus From the IOIBD. Gastroenterology 160:5, pages 1452-1460.e21.
Crossref
Crossref
F. Juliao-Baños, F. Puentes, R. López, M.A. Saffon, G. Reyes, V. Parra, M.T. Galiano, M. Barraza, J. Molano, E. Álvarez, R. Corrales, L.E. Vargas, F. Gil, P. Álvarez, L. Limas, R. Prieto, P. Yance, F. Díaz, J. Bareño, Fabián Juliao-Baños, Mateo Arrubla, Joselyn Camargo, Fabián Puentes, Lázaro Arango, Rocío López, Rafael García, Belén Mendoza, María A. Saffon, Luis F. Roldan, Julio Zuleta, Gustavo Reyes, Viviana Parra, Cristian Flórez, Edilberto Nuñez, María T. Galiano, Marcos Barraza, Isabel C. Sanchez, Jenny L. Molano, Jorge I. Lizarazo, Iván Cuellar, Eligio Álvarez, Rubén Corrales, Fabio Gil, Luz E. Vargas, Patricia Álvarez, Luis M. Limas, Robín Prieto, Hernán Ballén, Lidsay Delgado, Paola Yance & Felha Díaz. (2021) Characterization of inflammatory bowel disease in Colombia: Results of a national register. Revista de Gastroenterología de México (English Edition) 86:2, pages 153-162.
Crossref
Crossref
F. Juliao-Baños, F. Puentes, R. López, M.A. Saffon, G. Reyes, V. Parra, M.T. Galiano, M. Barraza, J. Molano, E. Álvarez, R. Corrales, L.E. Vargas, F. Gil, P. Álvarez, L. Limas, R. Prieto, P. Yance, F. Díaz, J. Bareño, Fabián Juliao-Baños, Mateo Arrubla, Joselyn Camargo, Fabián Puentes, Lázaro Arango, Rocío López, Rafael García, Belén Mendoza, María A. Saffon, Luis F. Roldan, Julio Zuleta, Gustavo Reyes, Viviana Parra, Cristian Flórez, Edilberto Nuñez, María T. Galiano, Marcos Barraza, Isabel C. Sanchez, Jenny L. Molano, Jorge I. Lizarazo, Iván Cuellar, Eligio Álvarez, Rubén Corrales, Fabio Gil, Luz E. Vargas, Patricia Álvarez, Luis M. Limas, Robín Prieto, Hernán Ballén, Lidsay Delgado, Paola Yance & Felha Díaz. (2021) Caracterización de la enfermedad inflamatoria intestinal en Colombia: resultados de un registro nacional. Revista de Gastroenterología de México 86:2, pages 153-162.
Crossref
Crossref
Gionata Fiorino, Silvio Danese, Giovanni Giacobazzi & Antonino Spinelli. (2021) Medical therapy versus surgery in moderate-to-severe ulcerative colitis. Digestive and Liver Disease 53:4, pages 403-408.
Crossref
Crossref
M Aloi, M Bramuzzo, L Norsa, S Arrigo, M Distante, E Miele, C Romano, C Giobbi, R Panceri, S Cucchiara, P Alvisi, G Lombardi, S Salvatore, S Gatti, C De Giacomo, D Knafelz, G Barera, S Provera & M Pastore. (2021) Disease Activity Patterns in the First 5 Years After Diagnosis in Children With Ulcerative Colitis: A Population-Based Study. Journal of Crohn's and Colitis 15:3, pages 367-374.
Crossref
Crossref
Bing-rong Li, Shi-yun Shao, Long Yuan, Ru Jia, Jian Sun, Qing Ji, Hua Sui, Li-hong Zhou, Yi Zhang, Hui Liu, Qi Li, Yan Wang & Bi-meng Zhang. (2021) Effects of mild moxibustion on intestinal microbiome and NLRP3 inflammasome in rats with 5-fluorouracil-induced intestinal mucositis. Journal of Integrative Medicine 19:2, pages 144-157.
Crossref
Crossref
Ruben J. Colman, Jasbir Dhaliwal & Michael J. Rosen. (2021) Predicting Therapeutic Response in Pediatric Ulcerative Colitis—A Journey Towards Precision Medicine. Frontiers in Pediatrics 9.
Crossref
Crossref
Sara van Gennep, Sanne W Evers, Svend T Rietdijk, Marieke E Gielen, Nanne K H de Boer, Krisztina B Gecse, Cyriel I J Ponsioen, Marjolijn Duijvestein, Geert R D’Haens, Angela G E M de Boer & Mark Löwenberg. (2021) High Disease Burden Drives Indirect Costs in Employed Inflammatory Bowel Disease Patients: The WORK-IBD Study. Inflammatory Bowel Diseases 27:3, pages 352-363.
Crossref
Crossref
Rosa Direito, João Rocha, Bruno Sepodes & Maria Eduardo-Figueira. (2021) Phenolic Compounds Impact on Rheumatoid Arthritis, Inflammatory Bowel Disease and Microbiota Modulation. Pharmaceutics 13:2, pages 145.
Crossref
Crossref
Yuriko Nishikawa, Nobuhiro Sato, Shintaro Tsukinaga, Kan Uchiyama, Shigeo Koido, Dai Ishikawa & Toshifumi Ohkusa. (2021) Long-term outcomes of antibiotic combination therapy for ulcerative colitis. Therapeutic Advances in Chronic Disease 12, pages 204062232110287.
Crossref
Crossref
M. E. Stellingwerf, W.A. Bemelman, M. Löwenberg, C. Y. Ponsioen, G. R. D'Haens, S. Dieren & C. J. Buskens. (2020) A nationwide database study on colectomy and colorectal cancer in ulcerative colitis: what is the role of appendectomy?. Colorectal Disease 23:1, pages 64-73.
Crossref
Crossref
D. I. Abdulganieva, A. L. Bakulev, E. A. Belousova, A. V. Veselov, T. V. Korotaeva, A. M. Lila, E. Yu. Loginova, E. V. Sokolovskiy, M. M. Khobeysh, M. V. Shapina & O. B. Shchukina. (2020) Early administration of genetically engineered biological agents for immune-mediated inflammatory diseases: opportunities and prospects. An experts’ opinion. Almanac of Clinical Medicine 48:6, pages 422-436.
Crossref
Crossref
. (2020) Characteristics and management of elderly-onset ulcerative colitis2．高齢発症潰瘍性大腸炎の特徴と治療. Nippon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics 57:4, pages 414-422.
Crossref
Crossref
Britt Christensen, Stephen B Hanauer, Peter R Gibson, Jerrold R Turner, John Hart & David T Rubin. (2020) Segmental Histological Normalisation Occurs in Ulcerative Colitis but Does Not Improve Clinical Outcomes. Journal of Crohn's and Colitis 14:10, pages 1345-1353.
Crossref
Crossref
Silvio Danese, Markus F. Neurath, Adam Kopoń, Salam F. Zakko, Timothy C. Simmons, Ronald Fogel, Corey A. Siegel, Remo Panaccione, Xiaojiang Zhan, Keith Usiskin & Denesh Chitkara. (2020) Effects of Apremilast, an Oral Inhibitor of Phosphodiesterase 4, in a Randomized Trial of Patients With Active Ulcerative Colitis. Clinical Gastroenterology and Hepatology 18:11, pages 2526-2534.e9.
Crossref
Crossref
D. I. Abdulganieva, A. L. Bakulev, E. A. Belousova, A. V. Veselov, T. V. Korotaeva, A. M. Lila, E. Yu. Loginova, E. V. Sokolovskiy, M. M. Khobeish, M. V. Shapina & O. B. Shchukina. (2020) Early prescription of biological agents for immune-mediated inflammatory diseases: opportunities and prospects. An expert’s opinion. Modern Rheumatology Journal 14:3, pages 7-18.
Crossref
Crossref
Gionata Fiorino, Theodore Lytras, Lisa Younge, Catarina Fidalgo, Sofie Coenen, Maria Chaparro, Mariangela Allocca, Ian Arnott, Peter Bossuyt, Johan Burisch, Marjo Campmans-Kuijpers, Lissy de Ridder, Axel Dignass, Ciara Drohan, Roger Feakins, Daniela Gilardi, Jan Grosek, Evelyn Groß, Ailsa Hart, Susanna Jäghult, Konstantinos Katsanos, Sanna Lönnfors, Yves Panis, Marko Perovic, Marieke Pierik, Jordi Rimola, Hagit Tulchinsky & Javier P Gisbert. (2020) Quality of Care Standards in Inflammatory Bowel Diseases: a European Crohn’s and Colitis Organisation [ECCO] Position Paper. Journal of Crohn's and Colitis 14:8, pages 1037-1048.
Crossref
Crossref
Matthew J Brookes, John Waller, Joseph C Cappelleri, Irene Modesto, Marco D DiBonaventura, Natalie Bohm, Ruth Mokgokong, Olivia Massey, Robert Wood & Danielle Bargo. (2020) Living with Ulcerative Colitis Study (LUCY) in England: a retrospective study evaluating healthcare resource utilisation and direct healthcare costs of postoperative care in ulcerative colitis. BMJ Open Gastroenterology 7:1, pages e000456.
Crossref
Crossref
Torsten Kucharzik, Sibylle Koletzko, Klaus Kannengießer & Axel Dignaß. (2020) Ulcerative Colitis—Diagnostic and Therapeutic Algorithms. Deutsches Ärzteblatt international.
Crossref
Crossref
Artin Galoosian, Mona Rezapour, Benny Liu, Taft Bhuket & Robert J. Wong. (2020) Race/Ethnicity-specific Disparities in In-Hospital Mortality and Hospital Charges Among Inflammatory Bowel Disease-related Hospitalizations in the United States. Journal of Clinical Gastroenterology 54:7, pages e63-e72.
Crossref
Crossref
Lorenzo Bertani, Giorgia Bodini, Maria Gloria Mumolo, Nicola de Bortoli, Linda Ceccarelli, Leonardo Frazzoni, Gherardo Tapete, Eleonora Albano, Maria Corina Plaz Torres, Massimo Bellini, Edoardo Savarino, Vincenzo Savarino, Santino Marchi & Francesco Costa. (2019) Corticosteroid Treatment at Diagnosis: An Analysis of Relapses, Disease Extension, and Colectomy Rate in Ulcerative Colitis. Digestive Diseases and Sciences 65:8, pages 2397-2402.
Crossref
Crossref
Jung Rock Moon, Chang Kyun Lee, Sung Noh Hong, Jong Pil Im, Byong Duk Ye, Jae Myung Cha, Sung-Ae Jung, Kang-Moon Lee, Dong Il Park, Yoon Tae Jeen, Young Sook Park, Jae Hee Cheon, Hyesung Kim, BoJeong Seo, Youngdoe Kim & Hyo Jong Kim. (2020) Unmet Psychosocial Needs of Patients with Newly Diagnosed Ulcerative Colitis: Results from the Nationwide Prospective Cohort Study in Korea. Gut and Liver 14:4, pages 459-467.
Crossref
Crossref
Dominic King, James Rees, Jemma Mytton, Philip Harvey, Tom Thomas, Rachael Cooney, Prashant Patel & Nigel Trudgill. (2020) The Outcomes of Emergency Admissions With Ulcerative Colitis Between 2007 and 2017 in England. Journal of Crohn's and Colitis 14:6, pages 764-772.
Crossref
Crossref
Carlos Arturo Rojas Rodríguez, Santiago Sánchez Londoño, Nelson Rojas, Mauricio Sepúlveda Copete, Jairo Alberto García Abadía, Diego Fernando Jiménez Rivera, Catalina Maldonado Gutiérrez & Angélica Tobón Guevara. (2020) Descripción clínico-epidemiológica de pacientes con enfermedad inflamatoria intestinal en una clínica de cuarto nivel en Cali. Revista Colombiana de Gastroenterología 35:2, pages 166-173.
Crossref
Crossref
Ashley Vachon & Frank I. Scott. (2020) The treatment approach to inflammatory bowel disease in 2020. Current Opinion in Gastroenterology 36:4, pages 247-256.
Crossref
Crossref
Millie D Long, Timothy W Smith, Marco Dibonaventura, David Gruben, Danielle Bargo, Leonardo Salese & Daniel Quirk. (2020) Real-world Effectiveness of Advanced Therapies Among Patients With Moderate to Severe Ulcerative Colitis in the United States. Inflammatory Bowel Diseases 26:6, pages 941-948.
Crossref
Crossref
Johan Burisch, Hillel Vardi, Doron Schwartz, Michael Friger, Gediminas Kiudelis, Juozas Kupčinskas, Mathurin Fumery, Corinne Gower-Rousseau, Laszlo Lakatos, Peter L Lakatos, Renata D'Incà, Alessandro Sartini, Daniela Valpiani, Martina Giannotta, Naila Arebi, Dana Duricova, Martin Bortlik, Stefania Chetcuti Zammit, Pierre Ellul, Natalia Pedersen, Jens Kjeldsen, Jóngerð Maria Miné Midjord, Kári Rubek Nielsen, Karina Winther Andersen, Vibeke Andersen, Konstantinos H Katsanos, Dimitrios K Christodoulou, Viktor Domislovic, Zeljko Krznaric, Shaji Sebastian, Pia Oksanen, Pekka Collin, Luisa Barros, Fernando Magro, Riina Salupere, Hendrika Adriana Linda Kievit, Adrian Goldis, Ioannis P Kaimakliotis, Jens F Dahlerup, Carl Eriksson, Jonas Halfvarson, Alberto Fernandez, Vicent Hernandez, Svetlana Turcan, Elena Belousova, Ebbe Langholz, Pia Munkholm, Selwyn Odes, Niksa Turk, Silvija Cukovic-Cavka, Anastasia Nicolaou, Milan Lukas, Olga Shonová, Birgitte Blichfeldt, Dorte Marker, Katrine Carlsen, Petra Weimers, Clays Aalykke, Karen Kudsk, Ida Vind, Niels Thorsgaard, Alexandros Skamnelos, Dimitrios Politis, Zsuzsanna Vegh, Peterne Demenyi, Szabina Nemethne Kramli, Giualia Dal Piaz, Alessia Santini, Giulia Girardin, Limas Kupcinskas, Laimas Jonaitis, Irena Valantiene, Romanas Zykus, Ruta Kucinskiene, Daniela Lazar, Inna Nikulina, Luisa de Castro, Juan-Ramon Pineda, Santos Pereira, Jesus Martinez-Cadilla, Luciano Sanroman, Montserrat Figueira, David Martinez Ares, Jose-Ignacio Rodriguez-Prada, Amalia Carmona, Carlos Gonzalez-Portela, Ulla-Britt Widen, Sally Myers, Katherine Ashton & Emma Whitehead. (2020) Health-care costs of inflammatory bowel disease in a pan-European, community-based, inception cohort during 5 years of follow-up: a population-based study. The Lancet Gastroenterology & Hepatology 5:5, pages 454-464.
Crossref
Crossref
Pasquale Klepp, Stephan Brackmann, Milada Cvancarova, Marte Lie Hoivik, Øistein Hovde, Magne Henriksen, Gert Huppertz-Hauss, Tomm Bernklev, Ole Hoie, Iril Kempski-Monstad, Inger Camilla Solberg, Njaal Stray, Jorgen Jahnsen, Morten H Vatn & Bjorn Moum. (2020) Risk of colorectal cancer in a population-based study 20 years after diagnosis of ulcerative colitis: results from the IBSEN study. BMJ Open Gastroenterology 7:1, pages e000361.
Crossref
Crossref
Karen van Hoeve, Ilse Hoffman, André D’Hoore, Marc Ferrante & Séverine Vermeire. (2020) Long-term outcome of immunomodulator use in pediatric patients with inflammatory bowel disease. Digestive and Liver Disease 52:2, pages 164-172.
Crossref
Crossref
Jonathan A. Beard, Diana L. Franco & Benjamin H. Click. (2020) The Burden of Cost in Inflammatory Bowel Disease: A Medical Economic Perspective and the Future of Value-Based Care. Current Gastroenterology Reports 22:2.
Crossref
Crossref
Muzaffer Kahyaoglu, Nuran Gunay, Emrah Bayam, Yusuf Yilmaz, Cetin Gecmen, Kamil Ozdil & Cihangir Uyan. (2019) Atrial peak longitudinal strain may be predictive of pancolitis in patients with ulcerative colitis. Journal of Clinical Ultrasound 48:2, pages 102-107.
Crossref
Crossref
Yong Eun Park, Yehyun Park, Soo Jung Park, Tae Il Kim, Won Ho Kim, Jung Nam Kim, Na Rae Lee & Jae Hee Cheon. (2020) Is fasting beneficial for hospitalized patients with inflammatory bowel diseases?. Intestinal Research 18:1, pages 85-95.
Crossref
Crossref
Zahra GhafouriSaeid SeyyedianJafar NikbakhtEbrahim KouhsariSara BayatHamidreza ZargarGholamreza Houshmand. (2020) Effect of Sodium Cromoglycate on Acetic Acid-induced Ulcerative Colitis in Mice. The Korean Journal of Gastroenterology 75:1, pages 39.
Crossref
Crossref
Davide G. Ribaldone, Andrea Resegotti & Marco Astegiano. (2020) The therapy of chronic pouchitis. Minerva Gastroenterologica e Dietologica 65:4.
Crossref
Crossref
Laura Ramos, Alejandro Hernández Camba, Raquel de la Barreda Heusser, Milagros Vela, Inmaculada Alonso-Abreu, Esther Rodríguez G.Marta Carrillo, Carlos Tardillo, Yolanda Rodríguez, Andrés Figueroa Marrero, Daniel Ceballos, Noelia Cruz, Lilian Kolle-Casso & Alejandro Jiménez Sosa. (2020) Predictive factors of clinical response to treatment with anti-TNF agents in ulcerative colitis: what have we learned from our patients?. Revista Española de Enfermedades Digestivas 112.
Crossref
Crossref
Simon P. Borg-Bartolo, Ray Kiran Boyapati, Jack Satsangi & Rahul Kalla. (2020) Precision medicine in inflammatory bowel disease: concept, progress and challenges. F1000Research 9, pages 54.
Crossref
Crossref
Ross J Porter, Rahul Kalla & Gwo-Tzer Ho. (2020) Ulcerative colitis: Recent advances in the understanding of disease pathogenesis. F1000Research 9, pages 294.
Crossref
Crossref
Liang Chen, Jiaolan Yang, Leilei Fang, Wei Wu, Baisui Feng, Yanhong Shi, Mingming Sun, Xiaomin Sun & Zhanju Liu. (2020) The Degree of Ulcerative Colitis Burden of Luminal Inflammation score is superior to predicting medium- to long-term prognosis in patients with active ulcerative colitis. Therapeutic Advances in Gastroenterology 13, pages 175628482098121.
Crossref
Crossref
Pawel Petryszyn, Pawel Ekk-Cierniakowski & Grzegorz Zurakowski. (2020) Infliximab, adalimumab, golimumab, vedolizumab and tofacitinib in moderate to severe ulcerative colitis: comparative cost-effectiveness study in Poland. Therapeutic Advances in Gastroenterology 13, pages 175628482094117.
Crossref
Crossref
Jasmine Zanelli, Subashini Chandrapalan, Abhilasha Patel & Ramesh P. Arasaradnam. (2020) The impact of pre-operative biologic therapy on post-operative surgical outcomes in ulcerative colitis: a systematic review and meta-analysis. Therapeutic Advances in Gastroenterology 13, pages 175628482093708.
Crossref
Crossref
C. Fradet, J. Kern, P. Atanasov, D. Wirth & A. Borsi. (2020) Impact of surgery and its complications in ulcerative colitis patients in clinical practice: A systematic literature review of real-world evidence in Europe. International Journal of Surgery Open 22, pages 22-32.
Crossref
Crossref
Catherine Le Berre, Ashwin N. Ananthakrishnan, Silvio Danese, Siddharth Singh & Laurent Peyrin-Biroulet. (2020) Ulcerative Colitis and Crohn’s Disease Have Similar Burden and Goals for Treatment. Clinical Gastroenterology and Hepatology 18:1, pages 14-23.
Crossref
Crossref
Gerhard Rogler & Luc Biedermann. 2020. Chronisch-entzündliche Darmerkrankungen. Chronisch-entzündliche Darmerkrankungen
87
94
.
Yun Qiu, Baili Chen, Yufei Li, Shanshan Xiong, Shenghong Zhang, Yao He, Zhirong Zeng, Shomron Ben-Horin, Minhu Chen & Ren Mao. (2019) Risk factors and long-term outcome of disease extent progression in Asian patients with ulcerative colitis: a retrospective cohort study. BMC Gastroenterology 19:1.
Crossref
Crossref
Sanjay K. Murthy, Tushar Shukla, Lilia Antonova, Marc-Andre Belair, Tim Ramsay, Zane Gallinger, Geoffrey C. Nguyen & Eric I. Benchimol. (2019) Predictive models of disease burden at diagnosis in persons with adult-onset ulcerative colitis using health administrative data. BMC Gastroenterology 19:1.
Crossref
Crossref
R. Sabel, A.S. Fronza, L.Z.B. Carrenho, A. Maes, M.L. Barros, L.A.E. Pollo, M.W. Biavatti, K. D'Herde, P. Vandenabeele & M.R.O. Kreuger. (2019) Anti-inflammatory activity of the sesquiterpene lactone diacethylpiptocarphol in dextransulfate sodium-induced colitis in mice. Journal of Ethnopharmacology 245, pages 112186.
Crossref
Crossref
E. F. Stange & K. Herrlinger. (2019) Optimierung der konservativen (Nichtbiologika‑)Therapie bei chronisch-entzündlichen DarmerkrankungenOptimization of conservative (nonbiologics) treatment for inflammatory bowel diseases. Der Gastroenterologe 14:6, pages 431-440.
Crossref
Crossref
Jacob E. Ollech, David T. Rubin, Laura Glick, Roni Weisshof, Katia El Jurdi, Amanda Israel, Noa Krugliak Cleveland, Neil Hyman, Atsushi Sakuraba, Joel Pekow, Russell D. Cohen & Sushila R. Dalal. (2019) Ustekinumab Is Effective for the Treatment of Chronic Antibiotic-Refractory Pouchitis. Digestive Diseases and Sciences 64:12, pages 3596-3601.
Crossref
Crossref
Dana Rachel Berg, Jean-Frederic Colombel & Ryan Ungaro. (2019) The Role of Early Biologic Therapy in Inflammatory Bowel Disease. Inflammatory Bowel Diseases 25:12, pages 1896-1905.
Crossref
Crossref
Lorant Gonczi, Talat Bessissow & Peter Laszlo Lakatos. (2019) Disease monitoring strategies in inflammatory bowel diseases: What do we mean by ‘tight control’?. World Journal of Gastroenterology 25:41, pages 6172-6189.
Crossref
Crossref
Displaying 200 of 526 citing articles. Use the download link below to view the full list of citing articles.
Download full citations list